Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

AAV delivery of artificial miRNA targeting MAPT for the reduction of tau pathology in Alzheimer’s disease

1 Sept 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Nerve injury and regeneration
Share to RNA Interference and Gene Delivery

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40898616
DOI: 10.1016/j.ymthe.2025.08.052

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

AAV delivery of artificial miRNA targeting MAPT for the reduction of tau pathology in Alzheimer’s diseasePMID 40898616Read ↗

Preclinical Development of a Vectorized Artificial miRNA Gene Therapy for TauopathiesSemantic proximity Read ↗

The MIR-NAT <i>MAPT-AS1</i> does not regulate Tau expression in human neuronsSemantic proximity Read ↗

Evaluating the efficacy of commercially available antisense oligonucleotides to reduce mouse and human tau <i>in vivo</i>Semantic proximity Read ↗

Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trialSemantic proximity Read ↗

Tau reduction with artificial microRNAs modulates neuronal physiology and improves tauopathy phenotypes in mice.Semantic proximity Read ↗

CRISPR base editing-mediated correction of a tau mutation rescues cognitive decline in a mouse model of tauopathySemantic proximity Read ↗

Advancing the battle against Alzheimer's Disease: A focus on targeting tau pathology by antisense oligonucleotideSemantic proximity Read ↗

Persistent repression of tau in the brain using engineered zinc finger protein transcription factorsSemantic proximity Read ↗

Disease-modifying strategies in primary tauopathiesSemantic proximity Read ↗

Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s diseaseSemantic proximity Read ↗

Tau Silencing by siRNA in the P301S Mouse Model of TauopathySemantic proximity Read ↗

Gene Therapy Strategies for Alzheimer's Disease: An OverviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.